Pharmacokinetic Properties of Fast-acting Insulin Aspart Administered in Different Subcutaneous Injection Regions: Response to the commentary by Nuggehally R. Srinivas
Clin Drug Investig
.
2017 Sep;37(9):885-887.
doi: 10.1007/s40261-017-0539-7.
Authors
Tim Heise
1
,
Ulrike Hövelmann
2
,
Leszek Nosek
2
,
Bettina Sassenfeld
2
,
Karen Margrete Due Thomsen
3
,
Hanne Haahr
4
Affiliations
1
Profil, Neuss, Germany. tim.heise@profil.com.
2
Profil, Neuss, Germany.
3
Novo Nordisk, Aalborg Ø, Denmark.
4
Novo Nordisk, Søborg, Denmark.
PMID:
28597216
DOI:
10.1007/s40261-017-0539-7
No abstract available
Publication types
Letter
Comment
MeSH terms
Blood Glucose
Humans
Hypoglycemic Agents
Injections, Subcutaneous*
Insulin
Insulin Aspart*
Substances
Blood Glucose
Hypoglycemic Agents
Insulin
Insulin Aspart